¼¼°èÀÇ ·¹³¯¸®µµ¸¶À̵å(Lenalidomide) ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2032³â)
Global Lenalidomide Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
»óǰÄÚµå : 1457981
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2024³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 171 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,416,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,535,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,266,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

·¹³¯¸®µµ¸¶ÀÌµå ½ÃÀåÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 182¾ï 3,000¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 313¾ï ´Þ·¯ ±Ùó ½ÃÀå ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ 2024-2032³âÀÇ CAGRÀº 6.19%¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

·¹³¯¸®µµ¸¶À̵å´Â ƯÁ¤ ¾Ï, ƯÈ÷ ´Ù¹ß¼º °ñ¼öÁ¾°ú °ñ¼ö ÀÌÇü¼º ÁõÈıºÀÇ Ä¡·á¿¡ »ç¿ëµÇ´Â ¾à¹°ÀÔ´Ï´Ù. ·¹³¯¸®µµ¸¶À̵å´Â ¸é¿ªÁ¶ÀýÁ¦·Î ¾Ë·ÁÁø ¾àǰ Ŭ·¡½ºº°·Î ¼ÓÇϸç, ¸é¿ª°èÀÇ ¹ÝÀÀÀ» º¯È­½ÃÄÑ ¾Ï¼¼Æ÷ÀÇ Áõ½ÄÀ» ¾ïÁ¦ÇÕ´Ï´Ù.

½ÃÀå ¿ªÇÐ

·¹³¯¸®µµ¸¶ÀÌµå ½ÃÀåÀº Ç÷¾× ¾Ç¼º Á¾¾ç, ƯÈ÷ ´Ù¹ß¼º °ñ¼öÁ¾°ú °ñ¼öÀÌÇü¼º ÁõÈıºÀÇ À¯º´·ü È®´ë·Î ÇöÀúÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¸é¿ªÁ¶ÀýÁ¦ÀÎ ·¹³¯¸®µµ¸¶À̵å´Â ÀÌ·¯ÇÑ ÁúȯÀÇ Ä¡·á¿¡ È¿°úÀûÀÓÀÌ ÀÔÁõµÇ¾úÀ¸¸ç, ÀÓ»ó ÇöÀå¿¡¼­ÀÇ Ã¤¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÇöÀç ÁøÇàÁßÀÎ ¿¬±¸°³¹ß Ȱµ¿¿¡ ÀÇÇØ ´Ù¾çÇÑ ¾ÏÀÇ Ä¡·áÁ¦·Î¼­ÀÇ °¡´É¼ºÀÌ ¸ð»öµÇ°í ÀÖ¾î ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. °Ô´Ù°¡ À¯¸®ÇÑ º¸Çè »óȯ Á¤Ã¥°ú ¾à¹°ÀÇ Ä¡·á È¿°ú¿¡ ´ëÇÑ ÀÎÁöµµ Áõ°¡µµ ½ÃÀå ¼ºÀåÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Ç÷¾× Áúȯ°ú °ü·ÃµÈ Áß¿äÇÑ Àα¸Åë°èÇÐÀû ¿äÀÎÀÎ ¼¼°è °í·ÉÈ­ Àα¸ Áõ°¡´Â ÀÌ ¾à ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç°ú ÀáÀçÀûÀÎ ºÎÀÛ¿ë°ú °°Àº ƯÁ¤ ¿äÀÎÀÌ ·¹³¯¸®µµ¸¶ÀÌµå ½ÃÀåÀ» ¹æÇØÇÒ °¡´É¼ºÀÌ ³ô½À´Ï´Ù.

ÀÌ Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ µµ±¸´Â ·¹³¯¸®µµ¸¶ÀÌµå ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ·¹³¯¸®µµ¸¶ÀÌµå »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±ÙÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

·¹³¯¸®µµ¸¶ÀÌµå ½ÃÀå º¸°í¼­ÀÇ ÀÌ ¼½¼Ç¿¡¼­´Â ±¹°¡ ¹× Áö¿ª ¼öÁØ ºÎ¹®¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© Àü·«°¡°¡ °¢ Á¦Ç° ¶Ç´Â ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» ÆÄ¾ÇÇϰí ÇâÈÄ ±âȸ¸¦ Áö¿øÇÕ´Ï´Ù.

À¯Çüº°

¿ëµµº°

ÃÖÁ¾ »ç¿ëÀÚº°

Áö¿ª ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ ·¹³¯¸®µµ¸¶ÀÌµå ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ Àú¸íÇÑ ¸ðµç Áö¿ª¿¡¼­ÀÇ °¢ ¿ëµµ ºÎ¹® ¼ö¿ä¡¤ÃßÁ¤¡¤¿¹Ãø¿¡µµ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

Ä¿½ºÅÒ ¸ÞÀ̵åÀÇ ¿ä±¸°¡ ÀÖÀ¸¸é, ÀúÈñ¿¡°Ô ¿¬¶ôÇØ ÁÖ¼¼¿ä. ´ç»çÀÇ ¼³¹®Á¶»çÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ·¹³¯¸®µµ¸¶À̵å - »ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ·¹³¯¸®µµ¸¶ÀÌµå ¼¼°è ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦6Àå ·¹³¯¸®µµ¸¶ÀÌµå ¼¼°è ½ÃÀå ºÐ¼® : ¿ëµµº°

Á¦7Àå ·¹³¯¸®µµ¸¶ÀÌµå ¼¼°è ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦8Àå ·¹³¯¸®µµ¸¶ÀÌµå ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå ·¹³¯¸®µµ¸¶ÀÌµå ±â¾÷°æÀï ±¸µµ

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

JHS
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global demand for Lenalidomide Market is presumed to reach the market size of nearly USD 31.3 Billion by 2032 from USD 18.23 Billion in 2023 with a CAGR of 6.19% under the study period 2024 - 2032.

Lenalidomide is a medication used in the treatment of certain cancers, particularly multiple myeloma and myelodysplastic syndromes. It belongs to a class of drugs known as immunomodulatory agents, working to modify the immune system's response and inhibit the growth of cancer cells. lenalidomide is often prescribed in combination with other therapies for improved efficacy.

MARKET DYNAMICS

The lenalidomide market is witnessing significant growth, driven by the expanding prevalence of hematological malignancies, particularly multiple myeloma and myelodysplastic syndromes. Lenalidomide, an immunomodulatory drug, has demonstrated efficacy in treating these conditions, leading to increased adoption in clinical settings. Furthermore, ongoing research and development activities explore the drug's potential for treating various cancers, contributing to its market expansion. Additionally, favorable reimbursement policies and a growing awareness of the drug's therapeutic benefits foster market growth. The rise in aging populations globally, which is a significant demographic factor linked to these hematological disorders, is further fueling the demand for this medication. However, certain factors, such as stringent regulatory requirements and potential adverse side effects, will likely hamper the lenalidomide market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of lenalidomide. The growth and trends of lenalidomide industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the lenalidomide market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

By Application

By End-User

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Lenalidomide market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Lenalidomide market include Accord Healthcare, Cipla, Deva Pharma, Dr. Reddy's Laboratories Ltd., Glenmark Pharmaceuticals, Hetero, Hikma Pharmaceuticals, Lupin Limited, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., Viatris Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

2 . EXECUTIVE SUMMARY

3 . LENALIDOMIDE - INDUSTRY ANALYSIS

4 . VALUE CHAIN ANALYSIS

5 . GLOBAL LENALIDOMIDE MARKET ANALYSIS BY TYPE

6 . GLOBAL LENALIDOMIDE MARKET ANALYSIS BY APPLICATION

7 . GLOBAL LENALIDOMIDE MARKET ANALYSIS BY END-USER

8 . GLOBAL LENALIDOMIDE MARKET ANALYSIS BY GEOGRAPHY

9 . COMPETITIVE LANDSCAPE OF THE LENALIDOMIDE COMPANIES

10 . COMPANY PROFILES OF LENALIDOMIDE INDUSTRY

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â